Perrigo Acquires Omega Pharma For $3.6 Billion Euro

announced Thursday morning it will acquire Belgium-based Omega Pharma, a maker of consumer health products for 2.48 billion euro ($3.1 billion) in addition to assuming 1.1 billion euro in debt. Ireland based Perrigo expects the transaction to be immediately accretive to adjusted earnings per share and double-digit accretion to its earnings in fiscal 2016. The combination of the two companies accounted for a pro forma last twelve month revenue of $5.7 billion. Perrigo expects a combination of the two companies will provide opportunities to cross sell additional products across a larger global platform with critical mass in all key European countries. "The combination of these two great companies accelerates Perrigo's international growth strategy, substantially diversifies our business streams and establishes a durable leadership position in the European OTC marketplace," stated Perrigo Chairman, President and CEO Joseph C. Papa in a